Results 101 to 110 of about 43,195 (149)

Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction. [PDF]

Res Pract Thromb Haemost
Kenny M, Pollitt AY, Patil S, Hiebner DW, Smolenski A, Lakic N, Fisher R, Alsufyani R, Lickert S, Vogel V, Schoen I.   +10 more
europepmc   +1 more source

Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target.

Blood
Benson TW, Pike MM, Spuzzillo A, Hicks SM, Ali S, Pham M, Mix DS, Brunner SI, Wadding-Lee C, Conrad KA, Russell HM, Jennings C, Coughlin TM, Aggarwal A, Lyden S, Mani K, Björck M, Wanhainen A, Bhandari R, Lipworth-Elliot L, Robinson-Cohen C, Caputo FJ, Shim S, Quesada O, Tourdot B, Edwards TL, Tranter M, Gardiner EE, Mackman N, Cameron SJ, Owens AP.   +30 more
europepmc   +1 more source

Impaired Glycoprotein VI-Mediated Signaling and Platelet Functional Responses in CD45 Knockout Mice. [PDF]

Thromb Haemost, 2019
Inamdar VV, Kostyak JC, Badolia R, Dangelmaier CA, Manne BK, Patel A, Kim S, Kunapuli SP.   +7 more
europepmc   +1 more source

Corrigendum to Contractility defects hinder glycoprotein VI-mediated platelet activation and affect platelet functions beyond clot contraction [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 1, January 2024, 102322]. [PDF]

Res Pract Thromb Haemost
Kenny M, Pollitt AY, Patil S, Hiebner DW, Smolenski A, Lakic N, Fisher R, Alsufyani R, Lickert S, Vogel V, Schoen I.   +10 more
europepmc   +1 more source

Platelet Activation Through Membrane Glycoprotein VI

Japanese Journal of Thrombosis and Hemostasis, 1996
TAKAYAMA, Hiroshi, ICHINOHE, Tatsuo, EZUMI, Yasuharu, TOMO, Kenjiro, HIRAI, Kenzo, OKUMA, Minoru   +5 more
openaire   +2 more sources

Dalby A, Mezzano D, Rivera J, et al. Introduction of an ancient founder glycoprotein VI mutation into the Chilean population. Blood Adv. 2022;6(22):5866-5869. [PDF]

Blood Adv
europepmc   +1 more source

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.

JAMA Cardiol, 2021
Mayer K, Hein-Rothweiler R, Schüpke S, Janisch M, Bernlochner I, Ndrepepa G, Sibbing D, Gori T, Borst O, Holdenrieder S, Kupka D, Petzold T, Bradaric C, Okrojek R, Leistner DM, Trippel TD, Münzel T, Landmesser U, Pieske B, Zeiher AM, Gawaz MP, Hapfelmeier A, Laugwitz KL, Schunkert H, Kastrati A, Massberg S.   +25 more
europepmc   +1 more source

Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability. [PDF]

Clin Appl Thromb Hemost, 2018
Sokol J, Skerenova M, Biringer K, Simurda T, Kubisz P, Stasko J.   +5 more
europepmc   +1 more source

Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces. [PDF]

Int J Mol Sci, 2019
Jooss NJ, De Simone I, Provenzale I, Fernández DI, Brouns SLN, Farndale RW, Henskens YMC, Kuijpers MJE, Ten Cate H, van der Meijden PEJ, Cavill R, Heemskerk JWM.   +11 more
europepmc   +1 more source

Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity? [PDF]

Res Pract Thromb Haemost, 2017
Rabbolini DJ, Gardiner EE, Morel-Kopp MC, Dunkley S, Jahangiri A, Lee CS, Stevenson WS, Ward CM.   +7 more
europepmc   +1 more source